Emna-Gouider-is-nominated-as-VP-NMO - EN2

Emna Gouider nominated as VP NMO

The World Federation of Hemophilia (WFH) is very pleased to announce that Emna Gouider has been nominated as Vice President, NMO, effective April 25, 2024, and for a two-year term.

Also available in: Français Español

Emna Gouider, MD, is a hematologist based in Tunisia, and has worked in the inherited bleeding disorders field for over two decades. She has been a volunteer with the Tunisian Association of Hemophilia—the WFH national member organization (NMO)—for nine years in various capacities, including as a board member. She is currently medical and scientific advisor for the NMO. She is also head of the Centre de traitement des hémophiles de Tunis hemophilia treatment centre (HTC) in Tunis.

By collaborating with the WFH as a leader with the Tunisian NMO, Gouider was able to build a successful national hemophilia treatment program, work closely with governments to set up a tendering process for clotting factor concentrates, set up a dedicated hemophilia treatment centre with a trained multi-disciplinary team, and introduce a low-dose prophylaxis program for children. She also worked to break some social taboos to increase focus on women and girls with bleeding disorders in her country.

Emna Gouiders’ invaluable experience will be a great asset to the WFH as Vice President, NMO. Please join us in welcoming her to the WFH Board of Directors.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.